Searchable abstracts of presentations at key conferences in endocrinology

ea0056p288 | Bone & Osteoporosis | ECE2018

Fragility index in type 2 diabetes for identification of patients with risk of osteoporotic fracture or prevalent fracture

Garcia-Martin Antonia , Dolores Aviles-Perez Maria , Garcia-Fontana Beatriz , Marquez-Herandez Maria Teresa , Hayon Maria , Munoz-Torres Manuel

Introduction: Diabetes mellitus is associated with an increased risk of osteoporotic fractures, which leads to an increased risk of disability and frailty.Aims: To assess the prevalence of frailty in type 2 diabetes and to analyze the relationship with bone mineral density (BMD) and Trabecular Bone Score (TBS), fracture risk and prevalent fractures.Methods: We carried out a cross-sectional study of 75 diabetic patients (65±7 y...

ea0099ep914 | Pituitary and Neuroendocrinology | ECE2024

Recurrence and predictive factors of the same in the endogenous cushing syndrome

Rodriguez Juarez Raul , Dolores Aviles Perez Maria , Martinez Silla Elena , Garcia Sanchez Javier , Canovas Noguera Laura , Luis Delgado Montoya Juan

Objective: Endogenous cushing syndrome (ECS) is a complex and rare disease. After treatment, 50% of cases have recurrence. The objective is to evaluate the prevalence of recurrences in patients diagnosed of ECS and its predictive factors.Materials and Methods: Analytical retrospective observational study with 19 ECS diagnoses cases followed-up from January 1999 to December 2023. Demographic (sex, age), clinical (cause, face plethora, fragile capillary, r...

ea0099p524 | Pituitary and Neuroendocrinology | ECE2024

Differences in the efficacy of second-line therapies on the biochemical control of acromegaly in patients with GH secreting pituitary neuroendocrine tumors (Pit-NETs) and GH and PRL cosecreting Pit-NETs

Araujo Castro Marta , Vicente Almudena , Cordido Fernando , Luis Menendez Torre Edelmiro , Pascual-Corrales Eider , Venegas Moreno Eva , Garcia Centeno Rogelio , Villar Taibo Rocio , Guerrero Fernando , Abellan Galiana Pablo , A Hanzu Felicia , Fajardo-Montanana Carmen , Novo Cristina , Camara Rosa , Dolores Aviles Perez Maria , Marazuela Monica , Biagetti Betina , Puig-Domingo Manel

Aim: To evaluate the efficacy of second-line therapies in patients with acromegaly caused by a GH and PRL cosecreting pituitary neuroendocrine tumor (GH&PRL-Pit-NET) and those caused by a GH-Pit-NET.Methods: A multicenter retrospective clinical practice study of 679 patients with acromegaly in follow-up in 33 tertiary hospitals (ACRO-SPAIN study). For this analysis, only patients on treatment with pasireotide or pegvisomant in monotherapy or in combi...